# OnCo record adagloxad-simolenin (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/adagloxad-simolenin/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "adagloxad-simolenin" ;
  schema:name "Adagloxad simolenin"@en ;
  schema:description "Adagloxad simolenin is OBI Pharma's vaccine against the tumour sugar Globo H, in the phase 3 GLORIA trial as adjuvant treatment for triple-negative breast cancer that expresses the antigen."@en ;
  schema:url <https://onco.cc/drugs/adagloxad-simolenin/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=OBI-822> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Carbohydrate antigen vaccine (Globo H conjugate) with the adjuvant OBI-821" ;
  onco:cancers <https://onco.cc/cancers/tnbc/> ;
  onco:technologies <https://onco.cc/technologies/dendritic-cell-vaccines/> ;
  onco:companies <https://onco.cc/companies/obi-pharma/> ;
  onco:trials <https://onco.cc/trials/nct03562637/> .